On 30 October 2025, Human Health Holdings Limited (1419) announced the publication of its 2025 Annual Report, along with the circular covering proposed general mandates to issue and repurchase shares, proposed re-election of directors, proposed re-appointment of auditor, expiry and proposed termination of the 2016 share option scheme, and the proposed renewal and adoption of a share option scheme (collectively referred to as the AGM Circular). The related notice of the 2025 annual general meeting and the proxy form have also been made available. These materials are accessible in both English and Chinese on the company’s official website (www.humanhealth.com.hk) under the “Investor Relations” section and on the website of Hong Kong Exchanges and Clearing Limited (www.hkexnews.hk).
Shareholders can locate the 2025 Annual Report by selecting “Annual Reports” and the AGM Circular by selecting “Circulars,” while the notice of the 2025 annual general meeting and the proxy form are posted under “Announcements and Notices.” Requests for printed copies, as well as any changes to the method of receiving future corporate communications and “Actionable Corporate Communications,” may be submitted by completing and sending the request form to the Hong Kong branch share registrar, Tricor Investor Services Limited, either by post or email. The same form can also be downloaded from the company’s website.
The company states that any preference to receive hard-copy versions remains valid unless revoked, superseded, or until it expires at the end of the following financial year. Shareholders encountering difficulty accessing the electronic versions or who wish to obtain printed copies may submit a written request and receive the necessary documents at no cost. The company also encourages registered shareholders to provide or update a functional email address to ensure timely delivery of documents via electronic means. For inquiries, shareholders may contact Tricor Investor Services Limited at (852) 2980 1333 during business hours or via email.